| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.18 | 7e-08 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.17 | 5e-06 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.21 | 2e-05 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.12 | 4e-05 |